Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrin formation is a critical biochemical process in blood coagulation, resulting in the transformation of soluble fibrinogen into insoluble fibrin strands that form the structural basis of a blood clot. This process is essential for hemostasis (the cessation of bleeding) and plays a central role in wound healing and thrombosis. The process begins with the activation of thrombin, a serine protease that cleaves fibrinogen to form fibrin monomers. These monomers polymerize to form protofibrils, which aggregate into thicker fibers, creating a three-dimensional network. Fibrin formation is regulated by thrombin concentration and environmental factors, and genetic variants can influence its dynamics. Abnormal regulation can lead to excessive or insufficient clotting, impacting hemostasis and thrombosis. Fibrinogen is encoded by three genes (*FGA*, *FGB*, *FGG*) clustered on human chromosome 4.
Inhibition of thrombin, inhibition of platelet activation, or enhancement of fibrinolysis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin Formation.